8.340USD-4.03%Mkt Cap: 811.83M $P/E: —1d ago
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel …
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap811.83M $
Enterprise Value532.84M $
Revenue (TTM)1.85M $
Gross Profit1.38M $
Net Income (TTM)-95.30M $
Revenue/Share0.0380 USD
Last Price8.340 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees174
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.51
PEG—
EV/EBITDA-5.64
EV/Revenue287.86
P/S438.59
P/B2.91
EPS (TTM)-2.22
EPS (Forward)-0.98
52W Range
2.85067% of range11.05
52W High11.05 USD
52W Low2.850 USD
Profitability
Gross Margin74.28%
Oper. Margin-4859.72%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-59.21%
ROA-33.99%
Growth
Revenue Growth-11.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-34.63M $
CapEx (TTM)2.39M $
FCF Margin-2844.73%
FCF Yield-6.49%
Net Debt-278.96M $
Net Debt/EBITDA2.95
Balance Sheet
Debt/Equity0.09
Current Ratio20.93
Quick Ratio20.66
Book Value/Sh2.864 USD
Cash/Share2.904 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)15.33 USD
Upside (mean)+83.9%
Target Range15.00 USD – 16.00 USD
$15.00+83.9% to mean$16.00
# Analysts3
Ownership
Shares Out.97.34M
Float60.31M
Insiders16.47%
Institutions66.92%
Short Interest
Short Ratio4.2d
Short % Float9.03%
Short % Out.6.32%
Shares Short6.15M
Short (prev mo.)5.42M
Technical
SMA 508.827 (-5.5%)
SMA 2006.127 (+36.1%)
Beta0.73
S&P 52W Chg20.25%
Avg Vol (30d)1.31M
Avg Vol (10d)1.29M
Technical Indicators
RSI (14)37.3
MACD-0.0196
MACD Signal0.2295
MACD Hist.-0.2492
BB Upper10.78 USD
BB Middle9.687 USD
BB Lower8.592 USD
BB Width22.61%
ATR (14)0.6073 USD
Vol Ratio (20d)1.45x